[Federal Register Volume 78, Number 35 (Thursday, February 21, 2013)]
[Notices]
[Page 12104]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2013-03885]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration; 
Cedarburg Pharmaceuticals, Inc.

    By Notice dated November 5, 2012, and published in the Federal 
Register on November 13, 2012, 77 FR 67676, Cedarburg Pharmaceuticals, 
Inc., 870 Badger Circle, Grafton, Wisconsin 53024, made application by 
renewal to the Drug Enforcement Administration (DEA) to be registered 
as a bulk manufacturer of the following basic classes of controlled 
substances:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
4-Anilino-N-phenethyl-4-piperidine ANPP)     II
 (8333).
Fentanyl (9801)............................  II
------------------------------------------------------------------------

    The company plans to manufacture the listed controlled substances 
in bulk for distribution to its customers. Regarding the drug code 
(8333), the company plans to use this controlled substance to 
manufacture another controlled substance.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a), and determined that the registration 
of Cedarburg Pharmaceuticals, Inc., to manufacture the listed basic 
classes of controlled substances is consistent with the public interest 
at this time. DEA has investigated Cedarburg Pharmaceuticals, Inc., to 
ensure that the company's registration is consistent with the public 
interest. The investigation has included inspection and testing of the 
company's physical security systems, verification of the company's 
compliance with state and local laws, and a review of the company's 
background and history.
    Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 
CFR 1301.33, the above named company is granted registration as a bulk 
manufacturer of the basic classes of controlled substances listed.

    Dated: February 8, 2013.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 2013-03885 Filed 2-20-13; 8:45 am]
BILLING CODE 4410-09-P